0001628280-20-003183.txt : 20200306
0001628280-20-003183.hdr.sgml : 20200306
20200306175251
ACCESSION NUMBER: 0001628280-20-003183
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200304
FILED AS OF DATE: 20200306
DATE AS OF CHANGE: 20200306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaul Samir
CENTRAL INDEX KEY: 0001501915
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38683
FILM NUMBER: 20696014
MAIL ADDRESS:
STREET 1: C/O KHOSLA VENTURES
STREET 2: 3000 SAND HILL ROAD, BLDG. 3, SUITE 170
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Guardant Health, Inc.
CENTRAL INDEX KEY: 0001576280
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 454139254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 PENOBSCOT DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 855-698-8887
MAIL ADDRESS:
STREET 1: 505 PENOBSCOT DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
wf-form4_158353515448686.xml
FORM 4
X0306
4
2020-03-04
0
0001576280
Guardant Health, Inc.
GH
0001501915
Kaul Samir
2128 SAND HILL ROAD
MENLO PARK
CA
94025
1
0
0
0
COMMON STOCK
2020-03-02
5
G
0
E
25000
0
D
112943
I
By Trust
COMMON STOCK
2020-03-04
4
S
0
4900
81.49
D
108043
I
By Trust
COMMON STOCK
2020-03-04
4
S
0
16800
82.53
D
91243
I
By Trust
COMMON STOCK
2020-03-04
4
S
0
3300
82.95
D
87943
I
By Trust
COMMON STOCK
1302
D
Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.88 to $81.86, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.90 to $82.89, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.90 to $83.24,inclusive. The Reporting Person undertakes to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, uponrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ John J. Demeter, as attorney-in-fact for Samir Kaul
2020-03-06